Key result
Soft tissue sarcomas are rare tumors requiring pretreatment imaging and core-needle biopsy for diagnosis, with metastasis and death remaining a significant problem in 50% of high-risk patients.
Population
Patients with soft tissue sarcomas
Design
Review
Authors
Loading...
Accurate pretreatment evaluation remains essential; leaves open molecularly targeted therapies for high-risk cases.
A general overview of soft tissue sarcomas, highlighting diagnosis, staging, and the need for molecularly based therapies.
Cormier et al. (2004) conducted a review in Soft tissue sarcomas. Soft tissue sarcomas are rare tumors requiring pretreatment imaging and core-needle biopsy for diagnosis, with metastasis and death remaining a significant problem in 50% of high-risk patients.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: